Searchable abstracts of presentations at key conferences in endocrinology

ea0005p196 | Reproduction | BES2003

Clinical features of patients with macroprolactinaemia

Teoh W , Strachan M , Don-Wauchope A , Beckett G , Stoddart M , Seth J

Macroprolactin (MPL) is a complex of prolactin (PRL) and IgG. It is considered to have little bioactivity and may account for a significant proportion of patients with 'idiopathic hyperprolactinaemia'. We determined the prevalence of macroprolactinaemia in patients with hyperprolactinaemia and examined the clinical features. An Immuno-1 system with PEG precipitation was used to identify MPL, with a recovery of <50% taken as indicating significant macroprolactinaemia.In ...

ea0089c38 | Clinical – Surgery/Applied Pathology | NANETS2022

Increased Incidence, Prevalence, and Surgical Management of Enteropancreatic Neuroendocrine Tumors Is Associated with Improvements in Survival - A Contemporary Analysis

Concors, MD Seth J , Tzeng, MD Ching-Wei D , Ikoma MD Naruhiko , Kim MD Michael , Cao, MD Hop Tran , Lee, MD Jeffery E , Katz, MD Matthew HG , Maxwell, MD, MBA Jessica E

Background: Neuroendocrine tumors (NETs) are increasing in incidence and prevalence. Small intestine, rectum, pancreas and appendix are the most common enteric sites of NETs, and when identified early, surgical resection can be curative. We hypothesized that observed increases in incidence and prevalence of NETs are primarily driven by earlier detection of loco-regional tumors. In turn, increases in incidence of early-stage tumors is associated with increases in resection and ...